Expertise in
6
conditions

Marc-oliver O. Grimm

Jena, TH, DE 
Expertise in
6
conditions
Jena, TH, DE 
OverviewLocationsClinical Research

Overview

Marc-oliver Grimm practices in Jena, Germany. Grimm is highly rated in 6 conditions, according to our data. Their top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Urothelial Cancer, Prostatic Artery Embolization, and Nephrectomy.

Their clinical research consists of co-authoring 144 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Jena, TH 07747, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Intervention Type: Drug
Study Drugs: abnobaVISCUM 900, Mitomycin C
Study Phase: Phase 3
Open vs Robotic Assisted Partial Nephrectomy
Open vs Robotic Assisted Partial Nephrectomy
Enrollment Status: Terminated
Publish Date: June 17, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of VPM1002BC in Patients With Recurrent Non-muscle Invasive Bladder Cancer After Standard BCG Therapy
A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of VPM1002BC in Patients With Recurrent Non-muscle Invasive Bladder Cancer After Standard BCG Therapy
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Drug
Study Drug: VPM1002BC
Study Phase: Phase 1/Phase 2
A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Biological
Study Drug: Nivolumab/Ipilimumab
Study Phase: Phase 2
A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
Enrollment Status: Unknown
Publish Date: November 03, 2021
Intervention Type: Biological
Study Drug: Nivolumab+Ipilimumab
Study Phase: Phase 2
View 4 Less Clinical Trials

144 Total Publications

Artificial Intelligence-Assisted Biparametric MRI for Detecting Prostate Cancer-A Comparative Multireader Multicase Accuracy Study.
Artificial Intelligence-Assisted Biparametric MRI for Detecting Prostate Cancer-A Comparative Multireader Multicase Accuracy Study.
Journal: Journal of clinical medicine
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Grimm's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile